Japanese Pharmacies Seek New Businesses As Competition Looms
This article was originally published in PharmAsia News
Japan's drugstores are looking for other markets as they anticipate a saturated market at home in the wake of new government deregulations. Many already are expanding the types of wares they sell or affiliating with large retailers. The pharmacies face a change in the law effective next spring when outlets other than pharmacies, such as department stores, are allowed to sell pharmaceuticals. Pharmacies see expansion into other markets as necessary because they would no longer be able to survive on sales of medicines alone. (Click here for more - a subscription may be required
You may also be interested in...
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.